Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
Category: Shortages
-
China’s Abrupt Covid Pivot Leaves Many Without Medicines
The New York Times – Business: -
Why It’s Hard to Predict What the Economy Will Look Like in 2023
The New York Times – Business:Years into the pandemic, it is still difficult to get a handle on what comes next for the economy by looking at examples from the past.
-
If There Is a ‘Male Malaise’ With Work, Could One Answer Be at Sea?
The New York Times – Business:As concerns about labor force participation among American men mount, maritime transportation firms are desperate for new mariners.
-
Flu and R.S.V. Increase Demand for Antibiotics and Antivirals
The New York Times – Business:An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply.
-
Higher Costs and Long Delays Push Developers to Adapt
The New York Times – Business:Hammered by supply chain woes and fluctuations in demand, builders have learned to become more adept managing challenges.
-
Job Openings Rose in September Despite Higher Interest Rates
The New York Times – Business:The labor market has remained stronger than expected even as the Federal Reserve has tried to get inflation under control.
-
F.D.A. Confirms Widespread Shortages of Adderall
The New York Times – Business:The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.
